Candel Therapeutics, Inc. CADL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $194.83M+62.7% | $119.73M+37.7% | $86.96M-13.6% | $100.69M+9.2% | $92.17M-10.2% | ||
| $416K0.0% | $416K+56.4% | $266K0.0% | $266K0.0% | $266K0.0% | ||
| $2.92M+76.0% | $1.66M-47.7% | $3.17M+8.6% | $2.92M+197% | $983K-14.5% | ||
| $197.75M+62.9% | $121.39M+34.7% | $90.13M-13.0% | $103.61M+11.2% | $93.15M-10.3% | ||
| $2.08M+26.4% | $1.64M+20.5% | $1.36M-17.8% | $1.66M-15.6% | $1.97M-10.3% | ||
| $1.57M-5.5% | $1.66M-5.1% | $1.75M+348% | $391K-16.5% | $468K-13.7% | ||
| $108K+24.1% | $87K+2.4% | $85K+88.9% | $45K-22.4% | $58K-7.9% | ||
| $201.92M+61.3% | $125.2M+33.8% | $93.6M-11.7% | $105.97M+10.5% | $95.91M-10.3% | ||
| $3.04M+169% | $1.13M+1.0% | $1.12M-42.8% | $1.95M+157% | $760K+221% | ||
| $89K0.0% | $89K-98.3% | $5.15M+19.2% | $4.32M+58.8% | $2.72M— | ||
| $67K-24.7% | $89K— | —— | —— | —— | ||
| —— | $0-100% | $4.23M-37.0% | $6.7M-26.9% | $9.17M-7.3% | ||
| $453K+1.8% | $445K+1.8% | $437K-26.4% | $594K+2.4% | $580K+2.5% | ||
| $7.05M-21.6% | $9M-17.7% | $10.93M-25.7% | $14.72M-26.7% | $20.07M-46.5% | ||
| $1.05M+3.9% | $1.01M+3.6% | $973K+3.6% | $939K+3.9% | $904K+3.9% | ||
| $1.34M-8.0% | $1.46M-7.2% | $1.57M+1,412% | $104K-59.5% | $257K-36.9% | ||
| $1.8M-5.7% | $1.9M-5.2% | $2.01M+188% | $698K-16.6% | $837K-14.0% | ||
| $63.89M-12.8% | $73.27M+444% | $13.47M-14.5% | $15.76M-25.8% | $21.23M-47.6% | ||
| $733K+33.3% | $550K0.0% | $550K+0.2% | $549K+11.4% | $493K+5.1% | ||
| $376.99M+33.6% | $282.21M+0.5% | $280.91M+0.4% | $279.73M+7.8% | $259.46M+0.4% | ||
| -$239.25M-3.8% | -$230.39M-14.7% | -$200.89M-5.9% | -$189.62M-2.6% | -$184.83M+3.8% | ||
| $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | ||
| $138.03M+166% | $51.92M-35.2% | $80.12M-11.2% | $90.21M+20.8% | $74.68M+12.6% | ||
| $201.92M+61.3% | $125.2M+33.8% | $93.6M-11.7% | $105.97M+10.5% | $95.91M-10.3% | ||
| $1.57M-5.5% | $1.66M-5.1% | $1.75M+348% | $391K-16.5% | $468K-13.7% | ||
| $1.57M-5.5% | $1.66M-5.1% | $1.75M+348% | $391K-16.5% | $468K-13.7% | ||
| $108K+24.1% | $87K+2.4% | $85K+88.9% | $45K-22.4% | $58K-7.9% | ||
| $1.57M-5.5% | $1.66M-5.1% | $1.75M+348% | $391K-16.5% | $468K-13.7% | ||
| $3.47M-52.6% | $7.33M+42.4% | $5.15M+19.2% | $4.32M+58.8% | $2.72M-46.8% | ||
| $3.47M-52.6% | $7.33M+42.4% | $5.15M+19.2% | $4.32M+58.8% | $2.72M-46.8% | ||
| $89K0.0% | $89K— | —— | —— | —— | ||
| $67K-24.7% | $89K— | —— | —— | —— | ||
| $2.84M-2.4% | $2.91M-59.6% | $7.21M-13.6% | $8.34M-23.6% | $10.91M-7.0% | ||
| $376.99M+33.6% | $282.21M+0.5% | $280.91M+0.4% | $279.73M+7.8% | $259.46M+0.4% | ||
| $733K+33.3% | $550K0.0% | $550K+0.2% | $549K+11.4% | $493K+5.1% | ||
| $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | $448K0.0% | ||
| $7.96M-49.0% | $15.6M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Candel Therapeutics, Inc.'s total assets?
- Candel Therapeutics, Inc. (CADL) holds $201.9M in total assets, up 110.5% year over year.
- How much debt does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. carries $2.8M in total debt against $138.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. holds $194.8M in cash and equivalents.
- Can Candel Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 28.05 — current assets exceed current liabilities.
- Where does Candel Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
